Be part of the knowledge.™

Antidepressant Patch and Drug Interactions

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr Leslie Lundt is joined by Dr. J Alexander Bodkin, Chief of the Clinical Psychopharmacology Research Program at the McLean Hospital and Assistant Professor in the Department of Psychiatry at Harvard Medical School, who explains which drug-drug interactions are important when using the new antidepressant patch.

Alexander Bodkin, MD

Alexander Bodkin, MD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Recommended

Details

Presenters

Overview
Dr Leslie Lundt is joined by Dr. J Alexander Bodkin, Chief of the Clinical Psychopharmacology Research Program at the McLean Hospital and Assistant Professor in the Department of Psychiatry at Harvard Medical School, who explains which drug-drug interactions are important when using the new antidepressant patch.

Alexander Bodkin, MD

Alexander Bodkin, MD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy

IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis

New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure

Partnering with Patients: Building Effective Communication and Support in HF Care

A Practical Guide to Prescribing in HF

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA

Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies

The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC